"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."

During the past decade, Jacksonville Center for Clinical Research conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 79 clinical trials were completed, i.e. on average, 91.9% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 39 clinical trials were completed. i.e. 125.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jacksonville Center for Clinical Research" #1 sponsor was "Pfizer" with 32 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "AstraZeneca" with 6 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Amgen" with 6 trials sponsored. Other sponsors include 138 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jacksonville Center for Clinical Research" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Cardiokine Biopharma, LLC" with 2 trials as a collaborator and "Integrium" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Jacksonville Center for Clinical Research" are "Alzheimer Disease" (7 trials), "Alzheimer's Disease" (7 trials), "Hypertension" (7 trials), "Heart Failure" (6 trials) and "Influenza" (6 trials). Many other conditions were trialed in "Jacksonville Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Jacksonville Center for Clinical Research" are "Drug" (166 trials), "Biological" (24 trials), "Device" (16 trials), "Other" (16 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (87 trials), "placebo" (9 trials), "Donanemab" (4 trials), "Naproxen" (4 trials) and "Apixaban" (3 trials). Other intervention names were less common.

The vast majority of trials in "Jacksonville Center for Clinical Research" are 193 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Jacksonville Center for Clinical Research". undefined are not yet recruiting, 13 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 141 completed trials in Jacksonville Center for Clinical Research, 1 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Jacksonville Center for Clinical Research, 12 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 10 trials that are defined as “Not Applicable".